Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Chinese Patent Office
Julphar
Daiichi Sankyo
Teva
UBS

Generated: May 25, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,560,120

« Back to Dashboard

Which drugs does patent 7,560,120 protect, and when does it expire?

Patent 7,560,120 protects DEXYCU KIT and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 7,560,120
Title:Vehicles for delivery of biologically active substances
Abstract: A formulation containing one or more biologically active substances dissolved, dispersed, emulsified, or suspended within a vehicle of one or more citric acid esters and/or citric acid ethers. Methods for making and using are disclosed, as are kits for administration of the pharmaceutical formulation.
Inventor(s): Shukla; Atul J. (Cordova, TN), Johnson; James R. (Germantown, TN), Sun; Yichun (Germantown, TN), Cooper; Robert (Starkville, MS), Boring; Gregg (Starkville, MS), Scruggs; Dan (Starkville, MS)
Assignee: University of Tennessee Research Foundation (Knoxville, TN)
Application Number:11/194,885
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,560,120
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 7,560,120

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Eyepoint Pharms DEXYCU KIT dexamethasone SUSPENSION;INTRAOCULAR 208912-001 Feb 9, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Boehringer Ingelheim
Federal Trade Commission
Colorcon
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.